| Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial MS George, SH Lisanby, D Avery, WM McDonald, V Durkalski, ... Archives of general psychiatry 67 (5), 507-516, 2010 | 1205 | 2010 |
| Zero-inflated and hurdle models of count data with extra zeros: examples from an HIV-risk reduction intervention trial MC Hu, M Pavlicova, EV Nunes The American journal of drug and alcohol abuse 37 (5), 367-375, 2011 | 440 | 2011 |
| Effects of spatial smoothing on fMRI group inferences M Mikl, R Mareček, P Hluštík, M Pavlicová, A Drastich, P Chlebus, ... Magnetic resonance imaging 26 (4), 490-503, 2008 | 345 | 2008 |
| Fever after subarachnoid hemorrhage: risk factors and impact on outcome A Fernandez, JM Schmidt, J Claassen, M Pavlicova, D Huddleston, ... Neurology 68 (13), 1013-1019, 2007 | 312 | 2007 |
| Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial FR Levin, JJ Mariani, DJ Brooks, M Pavlicova, W Cheng, EV Nunes Drug and alcohol dependence 116 (1-3), 142-150, 2011 | 264 | 2011 |
| Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial FR Schneier, Y Neria, M Pavlicova, E Hembree, EJ Suh, L Amsel, ... American Journal of Psychiatry 169 (1), 80-88, 2012 | 234 | 2012 |
| A single ketamine infusion combined with mindfulness-based behavioral modification to treat cocaine dependence: a randomized clinical trial E Dakwar, EV Nunes, CL Hart, RW Foltin, SJ Mathew, KM Carpenter, ... American Journal of Psychiatry 176 (11), 923-930, 2019 | 146 | 2019 |
| A single ketamine infusion combined with motivational enhancement therapy for alcohol use disorder: a randomized midazolam-controlled pilot trial E Dakwar, F Levin, CL Hart, C Basaraba, J Choi, M Pavlicova, EV Nunes American Journal of Psychiatry 177 (2), 125-133, 2020 | 139 | 2020 |
| Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment‐resistant depression WM McDonald, V Durkalski, ER Ball, PE Holtzheimer, M Pavlicova, ... Depression and anxiety 28 (11), 973-980, 2011 | 137 | 2011 |
| Reducing heavy drinking in HIV primary care: a randomized trial of brief intervention, with and without technological enhancement DS Hasin, E Aharonovich, A O'leary, E Greenstein, M Pavlicova, ... Addiction 108 (7), 1230-1240, 2013 | 121 | 2013 |
| Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: results of NIDA Clinical Trials Network Trial S Tross, ANC Campbell, LR Cohen, D Calsyn, M Pavlicova, GM Miele, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 48 (5), 581-589, 2008 | 118 | 2008 |
| Long-acting injectable naltrexone induction: a randomized trial of outpatient opioid detoxification with naltrexone versus buprenorphine M Sullivan, A Bisaga, M Pavlicova, CJ Choi, K Mishlen, KM Carpenter, ... American Journal of Psychiatry 174 (5), 459-467, 2017 | 111 | 2017 |
| Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial FR Levin, JJ Mariani, M Pavlicova, D Brooks, A Glass, A Mahony, ... Drug and alcohol dependence 159, 53-60, 2016 | 107 | 2016 |
| The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone A Bisaga, MA Sullivan, A Glass, K Mishlen, M Pavlicova, M Haney, ... Drug and alcohol dependence 154, 38-45, 2015 | 107 | 2015 |
| A randomized double‐blind, placebo‐controlled trial of venlafaxine‐extended release for co‐occurring cannabis dependence and depressive disorders FR Levin, J Mariani, DJ Brooks, M Pavlicova, EV Nunes, V Agosti, ... Addiction 108 (6), 1084-1094, 2013 | 106 | 2013 |
| Extended-release mixed amphetamine salts and topiramate for cocaine dependence: a randomized controlled trial JJ Mariani, M Pavlicova, A Bisaga, EV Nunes, DJ Brooks, FR Levin Biological psychiatry 72 (11), 950-956, 2012 | 97 | 2012 |
| The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid‐dependent volunteers ZD Cooper, KW Johnson, M Pavlicova, A Glass, SK Vosburg, MA Sullivan, ... Addiction biology 21 (4), 895-903, 2016 | 94 | 2016 |
| Enhancing the tropism of bacteria via genetically programmed biosensors T Chien, T Harimoto, B Kepecs, K Gray, C Coker, N Hou, K Pu, T Azad, ... Nature biomedical engineering 6 (1), 94-104, 2022 | 92 | 2022 |
| A randomized trial comparing extended-release injectable suspension and oral naltrexone, both combined with behavioral therapy, for the treatment of opioid use disorder MA Sullivan, A Bisaga, M Pavlicova, KM Carpenter, CJ Choi, K Mishlen, ... American Journal of Psychiatry 176 (2), 129-137, 2019 | 92 | 2019 |
| Long‐term efficacy of repeated daily prefrontal transcranial magnetic stimulation (tms) in treatmnt‐resistant depression A Mantovani, M Pavlicova, D Avery, Z Nahas, WM McDonald, CD Wajdik, ... Depression and anxiety 29 (10), 883-890, 2012 | 91 | 2012 |
Aimee CampbellColumbia University Irving Medical Center, Department of PsychiatryVerified email at cumc.columbia.edu
